Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression

BACKGROUND: Sorafenib is a first-line treatment option for advanced hepatocellular carcinoma (HCC) patients; however, survival predictors upon progression have not been well characterized. In the present study, we aimed to show the efficacy of multidisciplinary therapy for patients who had failed to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterol Res Pract
Hauptverfasser: Kondo, Masaaki, Numata, Kazushi, Hara, Koji, Nozaki, Akito, Fukuda, Hiroyuki, Chuma, Makoto, Maeda, Shin, Tanaka, Katsuaki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2017
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498900/
https://ncbi.nlm.nih.gov/pubmed/28717362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5728946
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge